Cognex (CGNX) Research & Development (2009 - 2026)

Cognex (CGNX) has reported Research & Development for 18 consecutive years, with $32.4 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Research & Development fell 2.15% year-over-year to $32.4 million; the trailing twelve-month figure through Jul 2026 stood at $140.6 million (up 3.67% YoY), and the FY2025 full-year result was $139.0 million, down 0.6% from the prior year.
• Research & Development slipped to $32.4 million in Q3 2026 per CGNX's latest filing, from $37.0 million in the prior quarter.
• Across five years, Research & Development topped out at $38.5 million in Q2 2023 and bottomed at $32.4 million in Q3 2026.
• Historically, Research & Development has averaged $34.9 million across 5 years, with a median of $34.8 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Research & Development slipped 6.57% in 2023, then climbed 10.82% in 2025.
• Over 5 years, Research & Development stood at $37.1 million in 2022, then declined by 6.57% to $34.7 million in 2023, then slipped by 6.21% to $32.5 million in 2024, then rose by 10.82% to $36.1 million in 2025, then retreated by 10.17% to $32.4 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $32.4 million, $37.0 million, and $36.1 million for Q3 2026, Q2 2026, and Q4 2025 respectively.